Nasal drug delivery in traditional Persian medicine

Jundishapur Journal of Natural Pharmaceutical Products

Volumn 8, Issue 3, 2013, Pages 144-148

  Zarshenas Mohammad, M M ^a,b   Zargaran, Arman ^c,d   Maüller, Johannes ^e   Mohagheghzadeh, Abdolali ^b,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Dosage Form; Herbal Medicine; Medicine; Traditional

Indexed keywords

NOSE DROPS; PLANT EXTRACT; UNCLASSIFIED DRUG; ZIZIPHUS SPINA-CHRISTI EXTRACT;

AERATION; ALHAGI MAURORUM; AROMA; ARTICLE; CEREBROVASCULAR ACCIDENT; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EPISTAXIS; EUPHORBIA; EUPHORBIA RESINIFERA; FACIAL NERVE PARALYSIS; FERULA; FERULA PERSICA; FIRST PASS EFFECT; FUMIGATION; GERMANDER; GLAUCIUM CORNICULATUM; HEADACHE; HERBAL MEDICINE; INHALATION; MALUS PUMILA; MEDICAL LITERATURE; MEDICINAL PLANT; MOLECULAR WEIGHT; NONHUMAN; NOSE CAVITY; ODOR; PARALYSIS; PARTICLE SIZE; POWDER; RUTA GRAVEOLENS; SMELLING; SUBSTANCE ABUSE; SUGARCANE; TEUCRIUM MONTANUM; TOBACCO; TRADITIONAL MEDICINE; VAPOR; VERTIGO; ZIZIPHUS SPINA-CHRISTI; ZYGOPHYLLACEAE; ZYGOPHYLLUM FABAGO;

EID: 84892515519     PISSN: 17357780     EISSN: 22287876     Source Type: Journal    
DOI: 10.17795/jjnpp-9990     Document Type: Article

References (41)

1. Borchardt JK. The Beginnings of Drug Therapy: Ancient Mesopotamian Medicine. Drug News Perspect. 2002;15(3):187-192.
2. Kasthuri KT, Radha R, Jayshree N, Austin A, Thirugnanasambantham P. Standardization and In Vitro Anti Inflammatory Studies of A Poly Herbal Oil Formulation-Megni. Res J Pharm Technol. 2010;3(3):792-4.
3. Buerki RA, Higby GJ. Dosage Forms and basic preparations: History. In: Swarbrick J, editor. Encyclopedia of Pharmaceutical Technology. London: Informa Healthcare; 2006. p. 948-74.
4. Levy G. Effect of Dosage Form on Drug Absorption a Frequent Variable in Clinical Pharmacology. Arch Int Pharmacodyn Ther. 1964;152:59-68.
5. Khaleghi Ghadiri M, Gorji A. Natural remedies for impotence in medieval Persia. Int J Impot Res. 2004;16(1):80-3.
6. Zargaran A, Zarshenas MM, Hosseinkhani A, Mehdizadeh A. Jawarish, a Persian traditional gastrointestinal dosage form. Pharm Hist (Lond). 2012;42(2):24-5.
7. Zargaran A, Zarshenas MM, Mehdizadeh A, Mohagheghzadeh A. Oxymel in medieval Persia. Pharm Hist (Lond). 2012;42(1):11-3.
8. Ramezany F, Ardakani MR. Ali ibn Hosein Ansari (1330-1404): a Persian pharmacist and his pharmacopoeia, Ekhtiyarat i Badi i. J Med Biogr. 2011;19(2):80-3.
9. Levy M. Medical Formulary or Aqrabadhin of Al-Kindi. University of Wisconsin Press; 1999.
10. Dhuria SV, Hanson LR, Frey WH, 2nd. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010;99(4):1654-73.
11. Alsarra IA, Hamed AY, Alanazi FK, El Maghraby GM. Vesicular Systems for Intranasal Drug Delivery. In: Jain JJ, editor. Drug Delivery to the Central Nervous System. New York: Humana Press, a part of Springer Science; 2010. p. 175-203.
12. Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol. 2001;53(1):3-21.
13. Putheti RR, Patil MC, Obire O. Nasal Drug delivery in Pharmaceutical and biotechnology: present and future. Sci Technol. 2009;4(3):1-12.
14. Heravi MG. [Qarabadin-e-salehi]. Tehran: Dar-ol-khalafeh; 1765.
15. Avicenna. [Canon of Medicine]. Tehran: Soroush Press; 1988.
16. Arzani A. [Qarabadin Ghaderi]. Tehran: Mohammadi Publication; 1861.
17. Shirazi SA. [Qarabadin-e-Kabir]. Tehran: Ostad Allah Qoli khan Qajar; 1855.
18. Azam Khan Cheshti H. [Qarabadin-Azam]. Tehran: Nezami Publication; 1809.
19. Shirazi M. [Makhzan ol Advieh]. Tehran: Intisharat va Amoozesh enghelab Islami Press; 1992.
20. [Program Book of Ph. D Degree in Traditional Persian Pharmacy]. Tehran: Ministry of Health and Medical Education; 2007.
21. Soltani A. [Dictionary of Medicinal Plants]. Tehran: Arjmand Press; 2004.
22. Amin G. [Popular Medicinal Plants of Iran]. Tehran: Tehran University Press; 2005.
23. Dymook W, Warden CJH, Hooper D. Pharmacographica Indica. London: Kegan Paul; 1893.
24. Baraniuk JN, Merck SJ. Neuroregulation of human nasal mucosa. Ann N Y Acad Sci. 2009;1170:604-9.
25. Cooke B, Ernst E. Aromatherapy: a systematic review. Br J Gen Pract. 2000;50(455):493-6.
26. De Ascentiis A, Bettini R, Caponetti G, Catellani PL, Peracchia MT, Santi P, et al. Delivery of nasal powders of beta-cyclodextrin by insufflation. Pharm Res. 1996;13(5):734-8.
27. Vardakou I, Pistos C, Spiliopoulou C. Drugs for youth via Internet and the example of mephedrone. Toxicol Lett. 2011;201(3):191-5.
28. Hill S, Sikand H, Lee J. A case report of seizure induced by bupropion nasal insufflation. Prim Care Companion J Clin Psychiatry. 2007;9(1):67-9.
29. Amruthesh S. Dentistry and Ayurveda-IV: classification and management of common oral diseases. Indian J Dent Res. 2008;19(1):52-61.
30. Bhatted S, Shukla VD, Thakar A, Bhatt NN. A study on Vasantika Vamana (therapeutic emesis in spring season)-A preventive measure for diseases of Kapha origin. Ayu. 2011;32(2):181-6.
31. Jadhav KR, Gambhire MN, Shaikh IM, Kadam VJ, Pisal SS. Nasal drug delivery system-factors affecting and applications. Current drug therapy. 2007;2(1):27-38.
32. Illum L. Nasal drug delivery-recent developments and future prospects. J Control Release. 2012;161(2):254-63.
33. Landis MS, Boyden T, Pegg S. Nasal-to-CNS drug delivery: where are we now and where are we heading? An industrial perspective. Ther Deliv. 2012;3(2):195-208.
34. Illum L. Nasal drug delivery--possibilities, problems and solutions. J Control Release. 2003;87(1-3):187-98.
35. Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Drug Discov Today. 2002;7(18):967-75.
36. Bertram U, Bodmeier R. In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form. Eur J Pharm Sci. 2006;27(1):62-71.
37. Schipper NG, Verhoef JC, Merkus FW. The nasal mucociliary clearance: relevance to nasal drug delivery. Pharm Res. 1991;8(7):807-14.
38. Bhat RB, Jacobs TV. Traditional herbal medicine in Transkei. J Ethnopharmacol. 1995;48(1):7-12.
39. Chui SH, Shek SL, Fong MY, Szeto YT, Chan K. A panel study to evaluate quality of life assessments in patients suffering from allergic rhinitis after treatment with a Chinese herbal nasal drop. Phytother Res. 2010;24(4):609-13.
40. Chan AS, Cheung MC, Sze SL, Leung WW, Shi D. An herbal nasal drop enhanced frontal and anterior cingulate cortex activity. Evid Based Complement Alternat Med. 2011;2011:543648.
41. Bhise SB, Yadav AV, Avachat AM, Malayandi R. Bioavailability of intranasal drug delivery system. Asian J Pharm. 2008;2(4):201.